ABBV241101C155000
- 0.00
- 0.000.00%
AbbVie Newsroom
AbbVie To Go Ex-Dividend On January 15th, 2025 With 1.64 USD Dividend Per Share
Express News | Abbvie : Cantor Fitzgerald Raises Target Price to $240 From $200
AbbVie Inc (ABBV) Q3 2024 Earnings Call Highlights: Strong Growth in Ex-Humira Platform and ...
Market Flips and Falls as Meta and MSTR Fall After Earnings | Wall Street Today
AbbVie Options Spot-On: On October 30th, 58,111 Contracts Were Traded, With 352.54K Open Interest
Sector Update: Health Care Stocks Softer Late Afternoon
Positive Outlook For Novartis As Company Capitalizes On Growing Treatment Opportunities, Analyst Highlights
AbbVie Inc. (ABBV) Q3 2024 Earnings Call Transcript Summary
AbbVie Inc. (ABBV) Q3 2024 Earnings Call Transcript
What's Behind AbbVie's Q3 Revenue Beat?
Evercore ISI Adjusts Price Target on AbbVie to $204 From $192
Wall Street Mixed, Semiconductors Tumble As AMD Disappoints, Alphabet Rallies, SMCI Plummets: What's Driving Markets Wednesday?
Market Climbs, SMCI Auditors Allege Mischief on Mischief Night | Live Stock
AbbVie's Options Frenzy: What You Need to Know
AbbVie Hits 4-week High
These Stocks Are Moving the Most Today: Super Micro, Alphabet, AMD, Lilly, Reddit, AbbVie, Qorvo, Garmin, and More -- Barrons.com
AbbVie Stock Rises After Earnings Beat, Dividend Hike -- Barrons.com
Express News | Abbvie Exec Says Co Cut 2024 U.S. Humira Sales Forecast by $400 Million to $7.4 Billion to Reflect More Shift in Volume, Including to Skyrizi and Rinvoq - Conf. Call
5 Stocks to Watch on Wednesday: MSFT, META, LLY and More
Express News | Abbvie Exec Says Co Now Seeing More Humira Molecule Volume Moving to Other Novel Mechanisms Than Previously Anticipated - Conf. Call